Status:
UNKNOWN
Improving Outcomes in Cardiac Arrest With Inhaled Nitric Oxide
Lead Sponsor:
Stony Brook University
Conditions:
Cardiac Arrest
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Sudden cardiac arrest (CA) is a leading cause of death worldwide. CA claims the lives of an estimated 300,000 Americans each year. Despite advances in cardiopulmonary resuscitation (CPR) methods, only...
Eligibility Criteria
Inclusion
- Age 18 years and above
- In-hospital cardiac arrest as defined by cessation of heartbeat
- Presence of Endotracheal Tube
Exclusion
- Age below 18 years
- Absence of Endotracheal Tube
- Patients with out-of-hospital cardiac arrest
- Patients involved in trauma and/or patients in the SICU or CTICU
- Preexisting intra-cerebral lesions such as any head injury (old or new), brain hematoma, cerebral hemorrhage or known frontal lobe disorders such as tumors
- Any patient with a terminal condition that cannot be treated (specifically any terminal malignancy, end stage lung fibrosis, chronic heart failure with an ejection fraction \<20%)
- Patients with do not resuscitate and/or do not intubate (DNR/DNI) status
- Therapeutic window has passed
Key Trial Info
Start Date :
August 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04134078
Start Date
August 1 2016
End Date
July 1 2022
Last Update
October 21 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stony Brook University
South Setauket, New York, United States, 11720